{{Rsnum
|rsid=307826
|Gene=FLT4
|Chromosome=5
|position=180624003
|Orientation=minus
|GMAF=0.05234
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FLT4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 80.5 | 18.6 | 0.9
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 99.3 | 0.7 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 99.3 | 0.7 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 84.0 | 16.0 | 0.0
| LWK | 98.2 | 1.8 | 0.0
| MEX | 81.0 | 19.0 | 0.0
| MKK | 94.2 | 5.8 | 0.0
| TSI | 78.4 | 21.6 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20223440
|Title=Allelic variations in angiogenic pathway genes are associated with preeclampsia
}}

{{PMID Auto
|PMID=22015057
|Title=Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
}}
{{GET Evidence
|gene=FLT4
|aa_change=Thr494Ala
|aa_change_short=T494A
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs307826
|overall_frequency_n=961
|overall_frequency_d=10758
|overall_frequency=0.0893289
|n_genomes=4
|n_genomes_annotated=0
|n_haplomes=4
|n_articles=0
|n_articles_annotated=0
|qualityscore_in_silico=1
|qualitycomment_in_silico=Y
|gene_in_genetests=Y
|pph2_score=0.008
|genetests_testable=Y
|genetests_reviewed=Y
|nblosum100=1
|autoscore=3
|n_web_uneval=5
}}

{{PMID Auto
|PMID=23788753
|Title=Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma
}}
{{PMID Auto
|PMID=23462807
|Title=Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.
|OA=1
}}

{{on chip | Affy GenomeWide 6}}